My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 235

    1.

    Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.

    Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.

    Diabetes Care. 1995 Aug;18(8):1133-9.PMID: 7587848 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

    Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.

    Psychosom Med. 1997 May-Jun;59(3):241-50.PMID: 9178335 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.

    Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.

    Arch Gen Psychiatry. 2005 Sep;62(9):1022-30.PMID: 16143734 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Alprazolam-reinforced medication use in outpatients with anxiety.

    Roache JD, Stanley MA, Creson DR, Shah NN, Meisch RA.

    Drug Alcohol Depend. 1997 May 2;45(3):143-55.PMID: 9179516 [PubMed - indexed for MEDLINE]Related articles

    5.

    Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

    Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

    Arch Gen Psychiatry. 2006 May;63(5):521-9.PMID: 16651509 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.

    Lydiard RB, Ballenger JC, Rickels K.

    J Clin Psychiatry. 1997;58 Suppl 11:11-8.PMID: 9363043 [PubMed - indexed for MEDLINE]Related articles

    7.

    Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.

    Möller HJ, Volz HP, Reimann IW, Stoll KD.

    J Clin Psychopharmacol. 2001 Feb;21(1):59-65.PMID: 11199949 [PubMed - indexed for MEDLINE]Related articles

    8.

    Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.

    Klein E, Colin V, Stolk J, Lenox RH.

    Am J Psychiatry. 1994 Dec;151(12):1760-6.PMID: 7977882 [PubMed - indexed for MEDLINE]Related articles

    9.

    Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.

    Cohn JB, Wilcox CS.

    Pharmacotherapy. 1984 Mar-Apr;4(2):93-8.PMID: 6144090 [PubMed - indexed for MEDLINE]Related articles

    10.

    A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

    Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

    Clin Ther. 2003 Apr;25(4):1074-95.PMID: 12809958 [PubMed - indexed for MEDLINE]Related articles

    11.

    Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

    Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

    Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.

    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.

    J Clin Psychopharmacol. 1990 Apr;10(2):112-8.PMID: 2187912 [PubMed - indexed for MEDLINE]Related articles

    13.

    A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

    Holman RR, Cull CA, Turner RC.

    Diabetes Care. 1999 Jun;22(6):960-4. Erratum in: Diabetes Care 1999 Nov;22(11):1922. PMID: 10372249 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

    Fonseca V, Rosenstock J, Patwardhan R, Salzman A.

    JAMA. 2000 Apr 5;283(13):1695-702. Erratum in: JAMA 2000 Sep 20;284(11):1384. PMID: 10755495 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    16.

    Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.

    Lustman PJ, Freedland KE, Griffith LS, Clouse RE.

    Diabetes Care. 2000 May;23(5):618-23.PMID: 10834419 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.

    Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL.

    Ann Intern Med. 2001 May 1;134(9 Pt 1):737-45.PMID: 11329231 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.

    Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL.

    Clin Ther. 2007 Jan;29(1):74-83.PMID: 17379048 [PubMed - indexed for MEDLINE]Related articles

    19.

    Alprazolam and diazepam in the treatment of generalized anxiety.

    Elie R, Lamontagne Y.

    J Clin Psychopharmacol. 1984 Jun;4(3):125-9.PMID: 6145726 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

    Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E.

    JAMA. 2000 Jun 21;283(23):3082-8.PMID: 10865302 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity